8-K 1 a6837548.htm MEDASSETS, INC. 8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported):

August 23, 2011

 

MedAssets, Inc.

 
(Exact name of registrant as specified in its charter)


Delaware

 

001-33881

 

51-0391128

 

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)


100 North Point Center E, Suite 200,

Alpharetta, Georgia

 

30022

 

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code:

678-323-2500

  Not Applicable
 
(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



Item 8.01   Other Events.

On August 23, 2011, MedAssets, Inc. (the "Company") issued a press release announcing that its Board of Directors authorized a stock repurchase program of up to $25 million of the Company’s common stock.  For additional information, a copy of the press release is attached as Exhibit 99.1 and is being incorporated herein by reference.

Item 9.01     Financial Statements and Exhibits.

(d) Exhibits

Exhibit

Number

 

Description

 

99.1

Press Release, dated August 23, 2011.

 

 

 

This exhibit is furnished pursuant to Item 8.01 and shall not be deemed to be “filed.”


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MedAssets, Inc.
 
 

August 23, 2011

By:

/s/ Charles O. Garner

Name: Charles O. Garner

Title: Executive Vice President and Chief Financial Officer


EXHIBIT INDEX


Exhibit No.

Description

 

99.1

Press release dated August 23, 2011.